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Abstract
Proper control of gene expression levels upon various perturbations is a fundamental aspect
of cellular robustness. Protein-level dosage compensation is one mechanism buffering per-
turbations to stoichiometry of multiprotein complexes through accelerated proteolysis of
unassembled subunits. Although N-terminal acetylation- and ubiquitin-mediated proteaso-
mal degradation by the Ac/N-end rule pathway enables selective compensation of excess
subunits, it is unclear how widespread this pathway contributes to stoichiometry control.
Here we report that dosage compensation depends only partially on the Ac/N-end rule path-
way. Our analysis of genetic interactions between 18 subunits and 12 quality control factors
in budding yeast demonstrated that multiple E3 ubiquitin ligases and N-acetyltransferases
are involved in dosage compensation. We find that N-acetyltransferases-mediated compen-
sation is not simply predictable from N-terminal sequence despite their sequence specificity
for N-acetylation. We also find that the compensation of Pop3 and Bet4 is due in large part
to a minor N-acetyltransferase NatD. Furthermore, canonical NatD substrates histone H2A/
H4 were compensated even in its absence, suggesting N-acetylation-independent stoichi-
ometry control. Our study reveals the complexity and robustness of the stoichiometry control
system.
Author summary
Quality control of multiprotein complexes is important for maintaining homeostasis in
cellular systems that are based on functional complexes. Proper stoichiometry of multi-
protein complexes is achieved by the balance between protein synthesis and degradation.
Recent studies showed that translation efficiency tends to scale with stoichiometry of
their subunits. On the other hand, although protein N-terminal acetylation- and ubiqui-
tin-mediated proteolysis pathway is involved in selective degradation of excess subunits,
it is unclear how widespread this pathway contributes to stoichiometry control due to the
lack of a systematic investigation using endogenous proteins. To better understand the
landscape of the stoichiometry control system, we examined genetic interactions between
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18 subunits and 12 quality control factors (E3 ubiquitin ligases and N-acetyltransferases),
in total 114 combinations. Our data suggest that N-acetyltransferases are partially respon-
sible for stoichiometry control and that N-acetylation-independent pathway is also
involved in selective degradation of excess subunits. Therefore, this study reveals the
complexity and robustness of the stoichiometry control system. Further dissection of this
complexity will help to understand the mechanisms buffering gene expression perturba-
tions and shaping proteome stoichiometry.
Introduction
Controlling intracellular protein concentration at the proper level is a critical aspect of cellular
systems. For example, it has been suggested that the cells regulate proteome concentration for
a constant rate of biochemical reactions [1–3]. Moreover, since a wide variety of stress
response pathways dynamically change the expression of proteins responsible for survival in
various challenging environments, it is obvious that the control of protein concentration is
important for coping with perturbations and maintaining cellular homeostasis.
Genome-wide studies measuring cellular robustness against genetic perturbations showed
that Saccharomyces cerevisiae cells are fragile against protein overexpression of a subset of the
genome [4, 5]. This finding indicates that the cell system is generally robust against genetic
perturbations to various biological processes. However, it is unclear how cells buffer such envi-
ronmental changes [6]. We recently reported that upon an increase in gene copy number,
approximately 10% of the yeast genome are transcribed linearly into mRNA levels but not
directly translated into protein levels [7]. Comprehensive analyses of aneuploid yeast and
mammalian cells also showed that approximately 20% of the genome exhibit this molecular
phenotype [8, 9]. Therefore, this phenomenon known as protein-level dosage compensation
may partially explain the buffering of gene expression perturbations.
Protein-level dosage compensation predominantly targets genes encoding subunits of multi-
protein complexes [7–10]. The concentration of the dosage-compensated proteins bidirectionally
changes in response to that of its partner subunits [7, 11]. These observations are consistent with a
hypothesis predicting the deleterious effects due to stoichiometric imbalance of the complex sub-
units on cell growth [5, 6, 12]. Another line of evidence for this prediction comes from ribosome
profiling analyses revealing a proportional synthesis strategy that enables translation efficiency to
scale with subunit stoichiometry [13, 14]. This finding shows that stoichiometric balance of multi-
protein complex subunits is mainly maintained at the translational level. In addition, this strategy
is conserved from bacteria to higher eukaryotes [14]. In this context, dosage compensation can be
recognized as a fail-safe mechanism that fine-tunes proteome stoichiometry [15].
The mechanism of dosage compensation is accelerated degradation of unassembled sub-
units by the ubiquitin–proteasome system [7, 11, 16, 17]. Multiple E3 ubiquitin ligases
involved in stoichiometry control were previously identified [11, 18, 19], but we lack an under-
standing of their relative contribution to the compensation of identical subunits [20]. Further-
more, the underlying mechanism for selective degradation of excess subunits is not well
understood. Although previous studies found evidence for selective compensation of Cog1
and Hcn1 in yeast and PLIN2 in mammalian cells by the Ac/N-end rule pathway [11, 21], it is
unclear how widespread this pathway contributes to the compensation. The Ac/N-end rule
pathway is one mechanism for protein degradation through the acetylation of N-terminal
amino acid by N-acetyltransferases (NATs). With the limited number of examples, N-acetyla-
tion was shown to act as a degradation signal (N-degron) recognized by specific E3 ubiquitin
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ligases (N-recognin) [11, 18, 22]. It has been hypothesized that N-degron of unassembled sub-
units is exposed and recognized by N-recognin, whereas that of assembled subunit is shielded
by the other subunits in the same complex and is inaccessible by N-recognin (Fig 1A) [11, 18,
23]. This model is consistent with the biological role of dosage compensation, but it remains to
be investigated whether the compensation depends on this pathway. Furthermore, the impact
of the Ac/N-end rule pathway on stoichiometry control differs between perturbed and
Fig 1. Genetic perturbation analysis of the stoichiometry control system. (A) Protein-level dosage compensation predominantly targets subunits of multiprotein
complexes. The Ac/N-end rule pathway is involved in the underlying mechanism for the selective compensation of unassembled subunits. (B) An experimental setup for
measuring the contribution of each quality control factor to dosage compensation. The untagged dosage-compensated protein was expressed from multicopy plasmid
pTOW40836 containing the native regulatory sequences, including promoter and 5´ and 3´ untranslated regions. If the target gene is subjected to dosage compensation,
the level of the TAP-tagged target protein expressed only from the chromosome decreases upon an increase in gene copy number (Multi) compared to vector control
(Single). The Multi/Single ratio is higher than that in WT cells in the deletion mutant of a gene encoding an E3 ubiquitin ligase or a catalytic subunit of each NAT, if the
deleted factor contributes to the compensation of the target gene.
https://doi.org/10.1371/journal.pgen.1009091.g001
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unperturbed conditions [11, 18, 24], which prompted us to estimate how widespread NATs-
mediated compensation occurs upon genetic perturbations.
In this study, we measured the contribution of E3 ubiquitin ligases and NATs to dosage
compensation of the RNase P/MRP subunits, which are the compensated proteins identified
in our previous study [7], in a systematic manner. We find that multiple E3 ubiquitin ligases
and NATs are involved in the compensation. We also find that the dependency of the compen-
sation on NATs is variable among tested subunits. Our findings suggest that dosage compensa-
tion does not completely depend on the Ac/N-end rule pathway and highlight the complexity
of the stoichiometry control system.
Results
Multiple E3 ubiquitin ligases Tom1 and Not4 are involved in dosage
compensation of identical subunits
Our previous study screened 54 genes on chromosome I of S. cerevisiae in order to unbiasedly
estimate how much of the genome encodes the compensated proteins, and we identified five
proteins (Rbg1, Mtw1, Pop5, Saw1, and Erp2) [7]. To investigate which E3 ubiquitin ligases
are involved in dosage compensation and their relative contribution, we examined whether
these proteins are less compensated in five deletion mutants of E3 ubiquitin ligase genes
(DOA10, NOT4, TOM1, SAN1, and UBR1) involved in the protein quality control system
including the N-end rule pathways: (i) Doa10 and Not4 are known as N-recognins in the Ac/
N-end rule pathway [11, 18], (ii) Tom1 is involved in degradation of a broad range of unas-
sembled ribosomal subunits [19], (iii) San1 is responsible for proteasomal degradation of aber-
rant nuclear proteins [25], and (iv) Ubr1 is N-recognin in the Arg/N-end rule pathway that is
suggested to complement the Ac/N-end rule pathway [26, 27]. Using a previously developed
method for identifying genes with dosage compensation (S1A Fig) [7], we found that the
amount of Pop5 in tom1Δ and not4Δ and Saw1 in doa10Δ was increased compared to wild-
type (WT) cells (S1B and S1C Fig). A recent systematic analysis of protein stability in doa10Δ
cells showed that the hydrophobicity of N-terminus negatively correlates with the protein sta-
bility [24]. Consistent with this finding, N-terminus of Saw1 is more hydrophobic than the
other proteins that are not stabilized in doa10Δ cells. However, we note that Pop5 with a
hydrophobic N-terminus was not stabilized in the absence of Doa10.
Pop5 is a subunit of the RNase P/MRP complexes comprising of eleven subunits [28].
These complexes share eight subunits: Pop1, Pop3, Pop4, Pop5, Pop6, Pop7, Pop8, and Rpp1,
while Rpr2 is included only in the RNase P and Snm1 and Rmp1 are included only in the
RNase MRP. We previously found that translation efficiency of POP5mRNA does not change
upon an increase in POP5 copy number by ribosome profiling [7]. In addition, translation effi-
ciency of the other subunits of the RNase P/MRP complexes, including Rpp1 and Pop8 which
form a subcomplex with Pop5 [29], is also not affected in the same condition. Therefore, stoi-
chiometry control of these complexes depends on protein degradation upon genetic perturba-
tions, and it is possible to more precisely assess its contribution to stoichiometry control by
analyzing the RNase P/MRP subunits.
Since most subunits of these complexes are subjected to dosage compensation [7], we
examined whether Tom1 and Not4 are involved in the compensation of the other subunits.
We used an experimental setup by which the TAP-tagged target protein expressed from only
one genomic locus is detected upon an increase in copy number of untagged version of the
same gene (Fig 1B and S2A–S2D Fig). We first compared protein levels between with and
without overexpression in WT, tom1Δ, or not4Δ cells (S2E Fig). This analysis showed a signifi-
cant decrease in the compensation of Pop4, Pop5, Pop6, Pop7, Pop8, Rpp1, Rpr2, and Rmp1
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in tom1Δ cells (Fig 2A and 2B), as well as Pop3, Pop4, Pop5, Pop7, Rpp1, and Rmp1 in not4Δ
cells (Fig 2D and 2E). Therefore, Tom1 and Not4 were involved in dosage compensation of
the RNase P/MRP subunits: Tom1 and Not4 target at least 8 and 6 out of 11 subunits, respec-
tively (Table 1).
We further examined whether Doa10 is also involved in stoichiometry control of the RNase
P/MRP subunits and found that all nine tested subunits were compensated in doa10Δ to the
same degree in WT cells (S1 and S3 Figs). Therefore, Doa10 is not involved in stoichiometry
control of the RNase P/MRP subunits, consistent with a previous study showing that Cog1 is
compensated by Not4 instead of Doa10 [11]. These observations suggest different substrate
preferences of E3 ubiquitin ligases responsible for the compensation. Indeed, Tom1 tends to
compensate nuclear-localized proteins, as described below (see Discussion).
We next compared protein levels between WT and tom1Δ or not4Δ cells with or without
overexpression of each subunit of the RNase P/MRP complexes (S2F Fig). This analysis
Fig 2. Tom1 and Not4 are involved in dosage compensation. (A) Western blots of the RNase P/MRP subunits in tom1Δ cells. The TAP-tagged subunit
expressed from the chromosome was detected with PAP. Pop1 and Snm1 were not detected in our experiments. A representative blot from three biological
replicates is shown. (B) Quantification of protein levels in the Multi condition relative to those in the Single condition in WT and tom1Δ cells. The average
fold change ± s.d. was calculated from three biological replicates. Statistical significance was determined by a two-tailed Welch’s t test (�p<0.05, ��p<0.01).
Dashed line represents the same expression level between the Single and Multi conditions. (C) Comparison of protein levels between WT and tom1Δ cells in
the Single or Multi conditions. The average fold change ± s.d. was calculated from three biological replicates. Dashed line represents the same expression level
between WT and tom1Δ cells. Pop6 and Rpr2 levels were marginally significantly increased in tom1Δ under the Single condition (p = 0.059 and 0.071,
respectively). (D–F) Same as in (A–C), except that shown are Western blots of the RNase P/MRP subunits in not4Δ cells (D) and their quantification (E, F).
Pop5, Pop6, and Rpr2 levels were significantly increased in not4Δ compared to WT cells under the Single condition (p<0.05).
https://doi.org/10.1371/journal.pgen.1009091.g002
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showed the higher level of Pop6 and Rpr2 in tom1Δ and Pop5, Pop6, and Rpr2 in not4Δ than
those in WT cells without an increase in gene copy number (Fig 2C and 2F, Single). As this
comparison is between vector controls in WT and mutant cells, Tom1 and Not4 may be
involved in degradation of these subunits in unperturbed conditions. In addition, since Pop6
was not subjected to Not4-mediated compensation, Not4 contributes to its degradation but
this is not accelerated upon overexpression.
Our analysis showed that Not4 contributes to the compensation of Rmp1 whose polylysine
sequence CKKKKKRKKKNK, close to the C-terminal (residues 182–193), induces translation
arrest coupled with Not4-mediated proteolysis [30]. Recent studies revealed that translation
arrest peptides are degraded by the ribosome quality control complex (RQC) [31]. The RQC-
mediated degradation of arrest peptides and the initiation of this pathway are mediated by E3
ubiquitin ligases Ltn1 and Hel2, respectively [32, 33]. To examine whether this clearance path-
way for arrest peptides is linked to dosage compensation, we measured the compensation
degree of Rmp1 in deletion mutants of LTN1 orHEL2 using the same experimental setup
shown in Fig 1B. We found that the compensation degree of Rmp1 in ltn1Δ and hel2Δ was
compatible with that in WT cells (S4 Fig). Our results suggest that perturbations to a quality
control pathway for the clearance of arrest peptides does not result in a decreased level of
Rmp1 compensation.
Dosage compensation of Pop6 and Pop7 occurs in response to their
intracellular concentration
Since both Pop6 and Pop7, which form the Pop6–Pop7 heterodimeric subcomplex [34, 35],
are subjected to dosage compensation (Fig 2), the amount of Pop6 and Pop7 may change in
response to that of partner subunits. We hypothesized that high POP7 dosage leads to changes
in the fraction of the stable/assembled and unstable/unassembled pools of Pop6 (Fig 3A, top).
Furthermore, since the mechanism of dosage compensation is accelerated degradation of
unassembled subunits, the balance of these subunit pools may be perturbed in the absence
of Tom1 or Not4 (Fig 3B, top). As expected (Fig 3A and 3B, bottom), we found that Pop6
was stabilized by an increase in POP7 dosage, and vice versa, in WT, tom1Δ, or not4Δ cells
(Fig 3C and 3D). These results indicate that dosage compensation of Pop6 and Pop7 occurs
bidirectionally in response to changes in intracellular concentration of each subunit:
accelerated degradation of Pop6/Pop7 upon high POP6/POP7 dosage (downward
Table 1. Responsible E3 ubiquitin ligases and NATs for dosage compensation of the RNase P/MRP subunits.
Subunit N-terminal first five amino acids Responsible E3 (Tom1 or Not4) Responsible NATs (Sequence-based) Responsible NATs (Experiment-based)
Pop1 MSGSL n.d. NatA n.d.
Pop3 MSGSL Not4 NatA NatD
Pop4 MDRTQ Tom1, Not4 NatB NatA
Pop5 MVRLK Tom1, Not4 NatA NatAa
Pop6 MINGV Tom1 NatC NatB
Pop7 MALKK Tom1, Not4 NatA not identified
Pop8 MGKKT Tom1 NatA NatB
Rpp1 MLVDL Tom1, Not4 NatC not identified
Rpr2 MGKKA Tom1 NatA NatB
Snm1 MNKDQ n.d. NatB n.d.
Rmp1 MDEMD Tom1, Not4 NatB NatA, NatB
a Pop5 was significantly more compensated in naa10Δ than in WT cells. n.d.: not detected
https://doi.org/10.1371/journal.pgen.1009091.t001
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compensation) and reduced degradation of Pop6/Pop7 upon high POP7/POP6 dosage
(upward compensation).
Upon increasing gene copy number of the partner subunit, the relative ratio of Pop6 and Pop7
in tom1Δ and not4Δ was lower than that in WT cells. This difference may reflect the regulation of
the compensation degree, as the amount of Pop6 and Pop7 was increased in both mutants without
changes in gene copy number (Fig 3C and 3D, +Vector). Therefore, Tom1 and Not4 impact the
balance of stable/unstable subunit pools of the Pop6–Pop7 heterodimeric subcomplex.
Fig 3. Bidirectional dosage compensation of the Pop6–Pop7 heterodimeric subcomplex. (A) A model for stoichiometry control of Pop6 and Pop7 in WT cells (top)
and an experimental setup for testing this model (bottom). Pop6 becomes more stable when in complex with the partner subunit Pop7, while unassembled Pop6 is less
stable (top left). Upon multicopy expression of Pop7, potentially degraded Pop6 becomes stable by forming the complex with excess Pop7 (top right). Pop6 level in vector
control is the steady state level (bottom left). If Pop6 turnover is reduced by high POP7 dosage, Pop6 level is increased compared to that in vector control (bottom right).
(B) Same as in (A), except that shown is the case of tom1Δ or not4Δ cells. Potentially degraded Pop6 in WT cells becomes stable in the absence of Tom1 or Not4 that are
responsible for Pop6 and Pop7 degradation (top left). Upon multicopy expression of Pop7, this undegraded fraction and the remaining unstable pool of Pop6 become
stable by forming the complex with excess Pop7 (top right). The steady state level of Pop6 in tom1Δ or not4Δ cells is higher than that in WT cells (bottom left). If the
turnover of Pop6 is further reduced by high POP7 dosage, it leads to a small increase in Pop6 level (bottom right). (C, D) Western blots of Pop6-TAP (C) and Pop7-TAP
(D) in WT, tom1Δ, and not4Δ cells. The TAP-tagged proteins were detected with PAP in the Single (+Vector: pTOW40836) and Multi (+POP6: pTOW40836-POP6,
+POP7: pTOW40836-POP7) conditions. Quantification of band intensities relative to the Single condition in each strain is shown. Coomassie staining of a 50-kDa
protein, corresponding to enolase, is shown as a loading control.
https://doi.org/10.1371/journal.pgen.1009091.g003
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NATs contribute to dosage compensation in a complex manner
S. cerevisiae has five NATs: NatA, NatB, NatC, NatD, and NatE whose catalytic subunits are respec-
tively Naa10, Naa20, Naa30, Naa40, and Naa50 [36]. NATs have different sequence specificities for
N-acetylation and their substrates can be classified by the first two N-terminal residues except
NatD that recognizes approximately five-residue sequence motifs[18, 36, 37]. As shown in Fig 4A,
based on the prediction from N-terminal amino acids, the RNase P/MRP subunits can be N-acety-
lated by NatA, NatB, or NatC. We examined whether the RNase P/MRP subunits are less
Fig 4. NATs contribute to dosage compensation in a complex manner. (A) The first five amino acids of the RNase P/MRP subunits (left). Based on these sequences,
NatA, NatB, or NatC are responsible for their N-acetylation (right). NatA-mediated acetylation requires removal of N-terminal Methionine by Met-aminopeptidases
Map1 and Map2 (MetAPs). (B) Western blots of the RNase P/MRP subunits in naa10Δ cells. The TAP-tagged subunit expressed from the chromosome was detected with
PAP. Pop1 and Snm1 were not detected in our experiments. A representative blot from three biological replicates is shown. (C) Quantification of protein levels in the
Multi condition relative to those in the Single condition in WT and naa10Δ cells. The average fold change ± s.d. was calculated from three biological replicates. Statistical
significance was determined by a two-tailed Welch’s t test (�p<0.05, ��p<0.01). Dashed line represents the same expression level between the Single and Multi conditions.
(D–K) Same as in (B, C), except that shown are Western blots of the RNase P/MRP subunits and their quantification in naa20Δ (D, E), naa30Δ (F, G), naa40Δ (H, I), or
naa50Δ (J, K) cells.
https://doi.org/10.1371/journal.pgen.1009091.g004
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compensated in naa10Δ, naa20Δ, naa30Δ, naa40Δ, or naa50Δ cells using the same experimental
setup described in Fig 1B. Our experiments showed that Pop4 and Rmp1 in naa10Δ (Fig 4B and
4C) and Pop6, Pop8, Rpr2, and Rmp1 in naa20Δ (Fig 4D and 4E) were significantly less compen-
sated than those in WT cells, while all tested subunits were compensated in naa30Δ or naa50Δ as
well as in WT cells (Fig 4F, 4G, 4J and 4K). Only Pop3 was uncompensated in naa40Δ cells (Fig 4H
and 4I), and the half-life of Pop3 was prolonged upon increasing POP3 copy number in naa40Δ
cells (S5A and S5B Fig). Of note, Pop3 was stabilized in naa10Δ compared to WT cells with or with-
out an increase in gene copy number (S6 Fig) (p<0.05, two-tailed Welch’s t test), suggesting the
involvement of NatA in Pop3 degradation even in unperturbed conditions. We also found that
Pop5 compensation was more pronounced in naa10Δ than in WT cells (Fig 4B and 4C), suggesting
that accelerated Pop5 degradation during dosage compensation is blocked by NatA.
To assess functional redundancy of NATs during dosage compensation, we generated
naa10Δ naa20Δ cells carrying TAP-tagged POP4 or RMP1 in the genome. However, this dou-
ble mutant showed synthetic growth defect (S7A Fig), and we did not observe the colony for-
mation of this double mutant when transformed with multicopy plasmids carrying POP4 or
RMP1. We thus measured the amount of Pop4 and Rmp1 without an increase in gene copy
number and found that it was not different from that in WT and the single mutants (S7B Fig).
We summarized the contribution of each NAT to the compensation of the RNase P/MRP
subunits, leading to several findings (Table 1). First, NatB-mediated compensation of Rmp1 is
the only case that can be expected from its N-terminal sequence. Second, the compensation of
Pop4 and Pop6 were engaged with NatA and NatB, respectively, although the compensation of
Pop4 and Pop6 through NatB and NatC was respectively expected from their sequence speci-
ficity for N-acetylation. Third, Rmp1 was compensated through multiple NATs (NatA and
NatB). Fourth, the compensation of Pop3 was due in large part to NatD but not NatA. Finally,
NATs for the compensation of Pop7 and Rpp1 were not identified. Taken together, the N-ter-
minal sequence cannot simply explain the contribution of NATs to the compensation. Fur-
thermore, NATs-mediated compensation of the RNase P/MRP subunits was mainly mediated
by NatA and NatB, although their impact on protein levels was limited (Fig 5). Therefore,
these results demonstrate the complexity of the stoichiometry control system that depends
only partially on NATs-mediated dosage compensation.
Furthermore, MD-starting proteins Pop4 and Rmp1 were compensated through NatA and
Not4, while NatB was also involved in Rmp1 compensation (Figs 2 and 4). Cog1 is also a MD-
starting protein that is compensated by NatB and Not4 upon its overexpression [11]. These
observations suggest that even though the first two N-terminal residues of substrate proteins
are the same, the compensation through the Ac/N-end rule pathway occurs by different com-
binations of NATs and E3 ligases.
Canonical NatD substrates, histone H2A/H4, are compensated in the
absence of NatD
As shown in Fig 4H and 4I, NatD efficiently contributes to the compensation of Pop3 that is
not identified as a NatD substrate [38]. To further examine whether NATs-mediated dosage
compensation is hardly predictable from N-terminal sequence, we next analyzed canonical
NatD substrates. NatD is more selective than the other NATs [36], and only histone H2A/H4
subunits are identified as its substrates [38–40]. These histone subunits are MS-starting pro-
teins that can be NatA substrates, but they are N-acetylated in the absence of Naa10 or its aux-
iliary subunit Naa15 [41]. Thus, we first tested whether NatD is involved in the compensation
of histone H2A/H4 subunits: Hta2, Hhf1, and Hhf2. We found that they were subjected to dos-
age compensation even in the absence of Naa40 (Fig 6A–6C), suggesting that NatD is involved
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in their N-acetylation but not degradation. Additionally, the compensation was observed not
only in naa40Δ but also in naa10Δ, naa20Δ, or naa30Δ as well as in WT cells (S8 Fig). We also
found that they all were significantly less compensated in tom1Δ cells, although the degree of
the compensation was different among them (Fig 6A–6C). These results suggest that Tom1--
mediated compensation of Hta2, Hhf1, and Hhf2 does not require NATs activity and that N-
acetylation and dosage compensation are not necessarily linked. Therefore, dosage compensa-
tion of histone H2A/H4 may be mediated by N-acetylation-independent pathway.
NatD-mediated dosage compensation of a MH-starting protein Bet4
The selectivity of NatD-mediated N-acetylation comes from a sequence motif recognized by
NatD and its substrate recognition site tailored for this motif [37]. The N-terminal of Pop3 is
SGSL after removal of N-terminal Met by Met-aminopeptidases, which is different from the
known motifs involved in histone subunits: SGGK (H2A) and SGRG (H4) [38]. We thus
examined whether Bet2, which is a MSGSL-starting protein and a subunit of the Bet2–Bet4
heterodimer [42], is subjected to NatD-mediated compensation. We found that Bet2 was com-
pensated by the same degree in naa40Δ and WT cells (Fig 6D), indicating that the first MSGSL
is not sufficient to determine the substrates of NatD-mediated compensation. Unexpectedly,
Fig 5. Relative contribution of Tom1, Not4, and NATs to dosage compensation of the RNase P/MRP subunits.
The heat map shows a quantitative summary of the contribution of Tom1, Not4, and NATs to dosage compensation of
the RNase P/MRP subunits. The basal level is the average fold change in WT cells. The contribution of each factor was
calculated as the average fold change in each mutant minus the basal level.
https://doi.org/10.1371/journal.pgen.1009091.g005
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Bet4 was remarkably less compensated in naa40Δ compared to WT cells (Fig 6E), and indeed,
Bet4 was stable upon increasing BET4 copy number in naa40Δ cells due to the prolonged half-
life (S5C and S5D Fig). This phenomenon was surprising because Bet4 is a MH-starting pro-
tein that is virtually not N-acetylated while N-acetylation of Bet4 was detected but its responsi-
ble NATs were not identified [36, 43].
We further examined the contribution of the other NATs to Bet4 compensation and found
that Bet4 was significantly less compensated in naa20Δ cells (Fig 6E). Thus, NatB and NatD
were involved in Bet4 compensation. We also found an increase in Bet4 compensation in
naa10Δ cells (Fig 6E), suggesting a NatA-mediated block of Bet4 degradation during the com-
pensation. Although these observations are similar to Rmp1 in naa10Δ and naa20Δ and Pop5
in naa10Δ cells (Fig 4B–4E), both effects of NATs deletion were observed only for Bet4. There-
fore, Bet4 was identified as the compensated protein whose stoichiometry is bidirectionally
controlled by multiple NATs upon genetic perturbations.
To examine whether NatB and NatD control Bet4 level in an additive manner, we analyzed
naa20Δ naa40Δ cells. We observed that Bet4 was compensated in this double mutant to the
same degree in naa20Δ and naa40Δ single mutants (Fig 6E). However, comparison of protein
Fig 6. Dissecting the complexity of NATs-mediated dosage compensation by focusing on NatD. (A–C) Tom1-mediated dosage compensation of NatD substrates does
not require Naa40. Western blot analysis of histone H2A/H4: Hta2-TAP (A), Hhf1-TAP (B), and Hhf2-TAP (C) in WT, naa40Δ, or tom1Δ cells. The TAP-tagged
subunits were detected with PAP. The average fold change ± s.d. was calculated from three biological replicates. (D) Western blot analysis of Bet2-TAP in naa40Δ cells
using PAP. The average fold change ± s.d. was calculated from four biological replicates. (E) Western blot analysis of Bet4-TAP in naa10Δ, naa20Δ, naa30Δ, naa40Δ,
naa50Δ, and naa20Δ naa40Δ cells using PAP. The average fold change ± s.d. was calculated from three biological replicates except the analysis of naa40Δ cells in eight
biological replicates. Statistical significance was determined by a two-tailed Welch’s t test (�p<0.05, ��p<0.01, ���p<0.001). Dashed line represents the same expression
level between the Single and Multi conditions. (F) Comparison of Bet4-TAP levels between WT and each mutant in the Single or Multi conditions. Statistical significance
was determined by a one-tailed Welch’s t test (�p<0.05, ��p<0.01). Dashed line represents the same expression level between WT and each mutant.
https://doi.org/10.1371/journal.pgen.1009091.g006
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levels between the single and double mutants showed that Bet4 was slightly but significantly
more abundant in naa20Δ naa40Δ cells (Fig 6F and S9 Fig). This small additive effect of the
double deletion seems to be consistent with the observation that Bet4 level was close to the
uncompensated level even in the single mutants. Because Bet4 was stabilized in the double
mutant despite an increase in BET4 copy number, both NatB and NatD independently con-
tribute to controlling Bet4 level even under unperturbed conditions. These results suggest that
their function in the context of Bet4 degradation is not redundant.
Discussion
To investigate how widespread the Ac/N-end rule pathway explains dosage compensation, we
systematically measured the contribution of E3 ubiquitin ligases and NATs to the compensa-
tion of the RNase P/MRP subunits (Figs 2 and 4). Our data consisting of 18 subunits and 12
quality control factors, in total 114 combinations, demonstrated that multiple E3 ubiquitin
ligases and NATs are involved in the compensation. NATs-mediated compensation was
observed for 7 out of 14 tested subunits: 6 of 9 subunits of the RNase P/MRP complexes, none
of three histone H2A/H4, and 1 of 2 subunits of the Bet2–Bet4 complex (Figs 4 and 6). How-
ever, given that the lack of NATs did not completely reduce the compensation of the tested
subunits except for Pop3 in naa40Δ and Bet4 in naa20Δ and naa40Δ cells, stoichiometry con-
trol of multiprotein complexes depends only partially on the Ac/N-end rule pathway.
In this study, we manipulated gene copy number to perturb cellular systems and elucidate
mechanisms for buffering gene expression perturbations. Our data showed that NATs contrib-
ute to proteolysis upon exogenous overexpression of the RNase P/MRP subunits, whereas
without overexpression the endogenous protein levels were almost not affected in NATs
mutants compared to E3 mutants (Fig 2C and 2F and S6 Fig). This is consistent with a recent
comprehensive analysis showing that N-acetylation rarely acts as a degradation signal in physi-
ological conditions in yeast [24]. Therefore, NATs-mediated proteolysis seems to be predomi-
nantly triggered upon genetic perturbations. It should be noted that because post-translational
dosage compensation is widely used to achieve proper stoichiometry in unperturbed yeast
cells [44], physiologically induced stoichiometric imbalance is also fine-tuned by the
compensation.
We identified Tom1 as a factor of the stoichiometry control system (Fig 2A and 2B), which
is consistent with Tom1-mediated degradation of excess ribosomal subunits [19]. It should be
noted that, as discussed in [19], basic isoelectric point is a common characteristic of known
Tom1 substrates (Cdc6, Hht2, Yra1, and Rpl26a) and the RNase P/MRP subunits except Pop8
(S10 Fig) [19, 45–47]. The weak electrical interaction between Tom1 with acidic isoelectric
point and Pop8 might explain why the compensation degree of Pop8 is lower than the other
subunits. Additionally, these substrates as well as Tom1 are nucleic acid binding and localize
to the nucleus [48]. These characteristics suggest the possibility that Tom1 tends to compen-
sate nucleic acid binding subunits.
We described the complexity of the stoichiometry control system (Fig 5, Table 1), as (i)
multiple E3 ligases Tom1 and Not4 are involved in the compensation of Pop4, Pop5, Pop7,
Rpp1, and Rmp1, (ii) N-terminal sequence is not necessarily a determinant of which NATs
contribute to dosage compensation, and (iii) multiple NATs are involved in the compensation
of Rmp1 and Bet4. Our findings thus suggest that this complexity reflects robustness of the
stoichiometry control system. Furthermore, as argued in [49], other mechanisms for sensing
unassembled subunits and correcting stoichiometric imbalance may exist. For example, the
most recent study showed that protein aggregation of excess subunits functions as the com-
pensation pathway in aneuploid yeast cells [50].
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Our observation that NatB and NatD were independently responsible for Bet4 compensation
is consistent with the higher substrate specificity of NatD than the other four NATs in yeast (Fig
6F and S9 Fig), although it is unclear whether this is the Bet4-specific molecular phenotype. If
NatB could be functionally redundant with NatD, Pop3 should be compensated through NatB
in naa40Δ and Bet4 should be compensated through NatB in naa40Δ and through NatD in
naa20Δ cells to similar levels in WT cells. Since this is opposite to our results, we speculate that
the function of NatB and NatD is not overlapping at least in the context of stoichiometry con-
trol. Furthermore, since we observed the stronger impact of deleting NAA20 than NAA10 on
cell growth and the synthetic growth defect phenotype of naa10Δ naa20Δ cells (S7 Fig), NatA
and NatB may be at least partially involved in the different process. This observation does not
eliminate the possibility of functional redundancy but rather suggest additive functions of NatA
and NatB. A systematic examination of mutants lacking multiple NATs is required to determine
whether there exist overlapping functions between or among NATs and subsequently to unveil
more general principles of their functional interactions. One line of support for this possibility
comes from the aspect of evolutionary conservation of NATs, as the expression of human NatF
(Naa60) increases the fraction of N-acetylated proteins from 68% to 78% in yeast [51], and
microscopic analysis of Arl3 whose subcellular localization depends on NatC-mediated N-acet-
ylation demonstrated functional redundancy between yeast NatC and human NatF [52].
The compensation of Pop3 in naa40Δ and Bet4 in naa20Δ and naa40Δ cells was almost
fully reduced (Figs 4H, 4I and 6E), supporting the dependency of stoichiometry control on the
Ac/N-end rule pathway [11]. However, these are rare cases in our study and the first examples of
NatD-mediated dosage compensation, and canonical NatD substrates histone H2A/H4 were
compensated even in the absence of Naa40 and the other NATs (Fig 6A–6C, S8 Fig). Importantly,
consistent with the stabilization of histone H3 subunit Hht2 by TOM1 deletion [46], H2A/H4
were less compensated in tom1Δ cells. These results suggest that unassembled subunits are selec-
tively degraded by not only the Ac/N-end rule but also other N-acetylation-independent path-
ways. This is further suggested by the observation that Rpp1 was almost fully uncompensated in
not4Δ but not in all NATs mutants (Figs 2D, 2E and 4), indicating that Not4-mediated compensa-
tion does not necessarily require NATs. Therefore, identifying new compensation E3 ligases is
important for better understanding the mechanism of dosage compensation. For example,
because a screen using deletion and temperature-sensitive mutants of all non-essential and a few
essential E3 ligase genes identifiedHEL1,HEL2, PEP5, and SNT2whose deletion results in defec-
tive degradation of excess histone H3/H4 [53], they seem to be candidates for the compensation
E3 responsible for nuclear-localized proteins. Indeed, although degradation of excess Rpl26a is
mainly mediated by Tom1, Rpl26a level is increased in pep5Δ compared to WT cells [19].
We also found that Pop5 and Bet4 were destabilized when they were overexpressed in
naa10Δ cells (Figs 4B, 4C and 6E). Similarly, previous studies showed that proteins with unace-
tylated N-terminal Met followed by a small hydrophobic residue and MN-starting proteins are
destabilized in naa30Δ and naa20Δ cells, respectively, by the Arg/N-end rule pathway [24, 54].
However, because N-terminal sequence of Pop5 (MV) and Bet4 (MH) are not appropriate for
these cases, their degradation in naa10Δ cells might be accelerated by unknown mechanisms.
We speculate that the complex stoichiometry is robustly maintained by switching degradation
pathways in response to perturbations in the stoichiometry control system. Indeed, the inter-
play between the Arg/N-end rule and the Ac/N-end rule pathways was proposed based on the
observation that the short-lived reporter protein and Msn4 are synergistically stabilized in
double mutants naa20Δ ubr1Δ and naa30Δ ubr1Δ, respectively [27, 54].
Quality control of multiprotein complexes impacts a broad range of biological processes
because of the fact that cellular systems are based on functional complexes. The RNase P and
MRP complexes are responsible for maturation of tRNA and rRNA, respectively [28].
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Additionally, Pop1, Pop6, and Pop7 are shared with telomerase [55]. Our finding of robust
control of dosage balance between Pop6 and Pop7 seems to be in line with their functional
importance (Fig 3). It is therefore possible that genome-wide analysis of dosage compensation
provides insights into the relationship between the functional importance and essentiality of
multiprotein complexes and how strictly the intracellular level of their subunits is controlled.
Moreover, the same analysis in NATs mutants leads to a more accurate estimation of how
widespread the Ac/N-end rule pathway contributes to stoichiometry control.
More generally, dosage compensation may play a role as a fail-safe mechanism for shaping
proteome stoichiometry as discussed above. In agreement with this concept, paralogous com-
plex subunits tend to compensate each other for modulating protein interactome [56, 57]. Fur-
thermore, proteolysis-mediated compensation pervasively buffers physiologically caused
stoichiometric imbalance during meiosis [44], which may explain how cells cope with a subset
of subunits overexpressed in unperturbed conditions [13]. This finding also suggests that dosage
compensation optimizes proteome stoichiometry along the progression of cellular development
in each stage of meiosis. Taken together, further dissection of the complexity and working prin-
ciples of the stoichiometry control system will help to understand buffering mechanism for pro-
teome concentration against both intrinsic and extrinsic genetic perturbations.
Materials and methods
Strains, plasmids, and media
For construction of the single deletion strains lacking a gene encoding the E3 ubiquitin ligase
(TOM1,NOT4,DOA10, LTN1, orHEL2) or N-acetyltransferase (NAA10, NAA20, NAA30,
NAA40, or NAA50) and carrying a TAP-tagged gene of interest, the deletion collection and the
TAP collection of haploid yeast (Dharmacon) were used. BY4741 carrying Pop4-TAP,
Rmp1-TAP, or Bet4-TAP were constructed in this study. Genomic DNA of each single deletion
strain was extracted, and then, each locus replaced with the kanMX4 cassette was amplified by
PCR with a primer library prepared in our previous study [5]. For construction of the double
deletion strains (naa10Δ naa20Δ and naa20Δ naa40Δ), the hphNT1 cassette amplified from
pFA6-hphNT1 plasmid was used for replacing NAA20 locus in the genome of naa10Δ carrying
Pop4-TAP or Rmp1-TAP and naa40Δ carrying Bet4-TAP, respectively. The TAP-tagged strains
were transformed with the PCR products by the lithium acetate method and selected on YPD
plates containing G418 (200 μg/mL) or HygB (300 μg/mL). For construction of plasmids, DNA
fragment of each target region was amplified from the genome and cloned into pTOW40836 by
homologous recombination in BY4741 cells. The TAP-tagged strains described above were
transformed with the plasmids and selected on SC medium lacking uracil.
Measurement of plasmid copy number
The plasmid copy number was measured by the gTOW technique [58]. The cells grown at log-
phase for Western blotting were harvested for the gTOW analysis from the same culture. In
short, 200 μL of the culture was centrifuged and the pelleted cells were suspended in 100 μL of
zymolyase solution [2.5 mg/mL Zymolyase-100T dissolved in 1.2 M sorbitol, 10 mM sodium
phosphate (pH7.5)] and incubated at 37˚C for 15 min for DNA extraction. The suspension was
heated at 100˚C for 10 min, cooled at –80˚C for 10 min, and again heated at 100˚C for 10 min.
After cooling down to room temperature (RT) followed by centrifugation, the supernatant was
subjected to real-time quantitative PCR with Lightcycler 480 (Roche). The primers for LEU3 in
the genome or leu2d gene in pTOW40836 and SYBR Green I Master (Roche) were used for
PCR. The resulting plasmid copy number was calculated based on the expression levels of LEU3
and leu2d genes according to the method described previously [58].
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Western blot analysis
Cells were grown at 30˚C in 2 mL of SC–Ura medium for overnight and then measured the
optical density at 600 nm (OD600) and inoculated into fresh medium at initial OD600 of 0.5 in
3 mL. After 4 h, 1 OD600 units were harvested at log-phase when OD600 was around 1. The
cells were treated with 1 mL of 0.2 N NaOH for 5 min at RT and centrifuged at 15,000 rpm for
1 min. The pelleted cells were suspended in 50 μL of 1× NuPAGE LDS Sample Buffer (Invitro-
gen) containing 100 mM DTT and heated at 100˚C for 5 min. For the analysis of the TAP-
tagged proteins, two-fold serially diluted lysates were analyzed as described below, and we con-
firmed that 0.025 OD600 units provide appropriate signal in the linear range. The extract
diluted 8-fold with 1× NuPAGE LDS Sample Buffer, corresponding to 0.025 OD600 units, was
separated by polyacrylamide gel electrophoresis with lithium dodecyl sulfate (SDS-PAGE) on
NuPAGE 4%–12% Bis-Tris Gel (Invitrogen). For the analysis of the GFP-tagged proteins, 0.2
OD600 units were subjected to SDS-PAGE. The separated proteins were transferred onto
PVDF membrane using the iBlot Transfer Stack PVDF membrane (Invitrogen). The blotted
membrane was treated with PBST [1× PBS, 0.1% Tween 20] for 10 min, and then blocked with
4% skim milk in PBST for 1 h at RT. The TAP-tagged proteins were probed with PAP (Sigma-
Aldrich) (1:2,000) for 1 h at RT. The GFP-tagged proteins were probed with anti-GFP antibody
(Roche) (1:1,000) and peroxidase-conjugated secondary antibody (Nichirei Biosciences)
(1:1,000) for 1 h at RT. After washing the membrane with PBST for 5 min for three times,
chemiluminescence was induced by adding 500 μL of SuperSignal West Femto Maximum Sen-
sitivity Substrate (Thermo Scientific) on the membrane and detected using LAS-4000 image
analyzer (Fujifilm) and ImageQuant LAS 4000 (GE Healthcare). Quantification of the band
intensity was carried out using ImageQuant TL (GE Healthcare) and the fold change was cal-
culated after background subtraction. After washing the membrane with sterile water for 5
min for three times, total proteins were visualized by Coomassie staining with SimplyBlue
SafeStain (Invitrogen) to confirm equal loading of proteins. The stained membrane was digi-
tized using LAS-4000 image analyzer and ImageQuant LAS 4000. Representative blots and
corresponding Coomassie stains are shown in S11 Fig.
For the analysis of histone H2A/H4 and the Bet2–Bet4 heterodimer, the harvested cells were
treated with 1 mL of 0.2 N NaOH for 5 min at RT. Cells were suspended in 1× NuPAGE LDS
Sample Buffer (Invitrogen) and then heated at 70˚C for 10 min. The supernatant corresponding
to 0.5 OD600 units was labeled with EzLabel FluoroNeo (ATTO) and subjected to SDS-PAGE,
followed by Western blot with PAP (Sigma-Aldrich) (1:2,000) as described above.
Cycloheximide chase assay
The degradation rate of Pop3-TAP and Bet4-TAP was measured as previously described [7].
Briefly, the log-phase culture corresponding to 1 OD600 unit of cells was harvested for time
point 0 and afterwards CHX was added to a final concentration of 200 μg/mL. Cells were har-
vested after 1, 2, 4, and 6.5 h, followed by total protein extraction in 1× NuPAGE LDS Sample
Buffer. The supernatant corresponding to 0.5 OD600 units was subjected to Western blot analy-
sis using PAP as described above. The remaining protein level at each time point was calcu-
lated against that at time point 0.
Supporting information
S1 Fig. Identification of E3 ubiquitin ligases involved in dosage compensation. (A) An
experimental setup for the screen of E3 ubiquitin ligases involved in dosage compensation.
The dosage-compensated proteins tagged with green fluorescent protein (GFP) were expressed
from multicopy plasmid pTOW40836 containing the native regulatory sequences, including
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promoter and 5´ and 3´ untranslated regions. If the tested E3 ligase is not responsible for deg-
radation of the target protein, the protein level is the same between WT and E3 mutant cells
(left and middle panels). On the other hand, if the target protein is degraded through the tested
E3 ligase, the protein level increases in the E3 mutant compared to WT cells (right and left
panels). (B) Western blot of the GFP-tagged dosage-compensated proteins in E3 mutants
using anti-GFP antibody. Coomassie staining of a 50-kDa protein, corresponding to enolase,
is shown as a loading control. (C) Gene copy number during dosage compensation. Western
blot detected the increased amount of Pop5 in tom1Δ and not4Δ and Saw1 in doa10Δ com-
pared to those in WT cells, although the plasmid copy number was almost the same among the
tested strains. Thus, Tom1 and Not4 and Doa10 were identified as E3 ubiquitin ligases
involved in degradation of Pop5 and Saw1, respectively. Bar graph represents the copy num-
bers of pTOW40836 carrying each of the indicated genes in WT or E3 mutants. The average
copy numbers ± s.d. were calculated from four technical replicates.
(TIF)
S2 Fig. Quantification of Western blot data. (A, B) Coomassie stained PVDF membrane (A)
after Western blotting with PAP (B) of two-fold serially diluted cell lysates prepared from
tom1Δ Pop3-TAP or Pop8-TAP cells cultured in the Single condition. (C) Quantification of
the area of a 50-kDa protein in (A). The signal intensity of each band was measured after back-
ground subtraction, and the net intensity was plotted on the y-axis. The amount of lysate from
tom1Δ Pop3-TAP and Pop8-TAP had a correlation coefficient (R2) of 0.99 and 0.97 with the
net intensity, respectively. (D) Quantification of the area of Pop3-TAP and Pop8-TAP in (B).
The signal intensity of each band was measured after background subtraction, and the net
intensity was plotted on the y-axis. The amount of lysate from tom1Δ Pop3-TAP and Pop8--
TAP had R2 of 0.99 and 0.99 with the net intensity, respectively. (E) Comparison of protein
levels between the Single and Multi conditions in WT or each mutant. Shown as an example is
Pop4-TAP in WT and tom1Δ cells. The band intensity of Pop4-TAP in the Multi condition
was divided by that in the Single condition in each strain. The full Coomassie band on the
PVDF membrane was used for normalization. (F) Comparison of protein levels between WT
and each mutant in the Single or Multi conditions. The band intensity of Pop4-TAP in tom1Δ
was divided by that in WT cells in each copy number condition. Data are from Fig 2A–2C.
(TIF)
S3 Fig. Western blot analysis of the RNase P/MRP subunits in doa10Δ cells. (A–C) Doa10
is not involved in dosage compensation of the RNase P/MRP subunits. Western blot analysis
of Pop3-TAP in two biological replicates (A) and the other RNase P/MRP subunits except for
Pop5 (B, C) using PAP in doa10Δ cells. Dashed line represents the same expression level
between the Single and Multi conditions.
(TIF)
S4 Fig. Western blot analysis of Rmp1-TAP in RQC mutants. Western blot analysis
of Rmp1-TAP using PAP in hel2Δ and ltn1Δ cells. Shown images are from the same
membrane.
(TIF)
S5 Fig. CHX chase experiments of Pop3-TAP and Bet4-TAP in naa40Δ cells. (A, B) CHX
chase experiments of Pop3-TAP in WT and naa40Δ cells. Western blot with PAP and
SDS-PAGE of a 50-kDa protein as a loading control (A). Quantification of Pop3-TAP levels in
the Single (left) or Multi (right) conditions (B). The average protein level ± s.d. was calculated
from three biological replicates. (C, D) Same as in (A, B), except that shown are Western blot
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and quantification of Bet4-TAP.
(TIF)
S6 Fig. The effect of NATs on the endogenous protein level of the RNase P/MRP subunits.
(A–E) Comparison of protein levels between WT and naa10Δ (A), naa20Δ (B), naa30Δ (C),
naa40Δ (D), or naa50Δ (E) cells in the Single or Multi conditions. The average fold change ± s.
d. was calculated from three biological replicates. Dashed line represents the same expression
level between WT and mutant cells. Data are from Fig 4B–4K.
(TIF)
S7 Fig. Synthetic growth defect of naa10Δ naa20Δ cells. (A) Spot test of naa10Δ naa20Δ
cells. Overnight cultures of indicated strains in YPD medium diluted to 0.1 OD600 and its
10-fold serial dilutions were spotted on YPD plates and incubated at 30˚C for 6 days. (B) West-
ern blots of Pop4-TAP (left) and Rmp1-TAP (right) in naa10Δ naa20Δ double mutant. All
strains were cultured in YPD medium due to no colony formation of naa10Δ naa20Δ cells
transformed with multicopy plasmids pTOW40836 carrying POP4 or RMP1 on SC–Ura plate.
Quantification from three biological replicates is shown below.
(TIF)
S8 Fig. Dosage compensation of Hhf2 in NATs mutants. Western blot analysis of Hhf2-TAP
in WT, naa10Δ, naa20Δ, naa30Δ, and naa40Δ cells. Hhf2-TAP was detected with PAP (top)
and quantified (bottom). Dashed line represents the same expression level between the Single
and Multi conditions.
(TIF)
S9 Fig. Bet4 was slightly but significantly more abundant in naa20Δ naa40Δ cells. (A, B)
Higher Bet4-TAP level in naa20Δ naa40Δ double mutant compared to the single mutants in
the Single (A) and Multi (B) conditions. Quantification of three biological replicates is shown.
Data are from Fig 6F.
(TIF)
S10 Fig. The isoelectric point of the RNase P/MRP subunits and Tom1 substrates. The iso-
electric point of Tom1 is 4.8, while that of the RNase P/MRP subunits, except Pop8, and
known Tom1 substrates is around 10.
(TIF)
S11 Fig. Representative blots and corresponding Coomassie stains of Western blots of the
RNase P/MRP subunits in E3 ligases or NATs mutants. (A–G) Shown are full length blots
and Coomassie stains used for the analysis of tom1Δ (A), not4Δ (B), naa10Δ (C), naa20Δ (D),
naa30Δ (E), naa40Δ (F), or naa50Δ (G) mutants, corresponding to Figs 2A, 2D, 4B, 4D, 4F,
4H and 4J.
(TIF)
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